IMMUCELL CORP
ICCC·452525306·US·Common Stock·Healthcare - Biotechnology-Activist
ICCC (IMMUCELL CORP) is held by 15 institutional investors as of Q1 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($1.6M), MORGAN STANLEY ($1.4M), RENAISSANCE TECHNOLOGIES LLC ($960,824). Net institutional sentiment: Mixed.
15
Holders
Avg rating(4 Elite)
$6.7M
Total Value
67% (16)
Fund Consensus
8 buying - 4 selling
Who's Trading
InsiderTOte Boekhorst Paul Francis OlivierBuy $76KJun 18, 2026
InsiderTSTomsche David ScottBuy $8KNov 25, 2025
InsiderTSTomsche David ScottBuy $8KNov 25, 2025
ActivistEAEjnar A. Knudsen III9.2%Nov 20, 2025
13F: Insider & Congress:
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer